Cogwise-Plus Tablet

Betahistine 16 mg + Vit D3 400IU + Ginkgo 60 mg + Piracetam 400 mg + Vinpocetine 5 mg Tablets

Cogwise-Plus Tablet — Betahistine 16 mg + Vitamin D3 400 IU + Ginkgo Biloba 60 mg + Piracetam 400 mg + Vinpocetine 5 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Betahistine 16 mg + Vitamin D3 400 IU + Ginkgo Biloba 60 mg + Piracetam 400 mg + Vinpocetine 5 mg
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 3300
Therapy Neurology — Multi-Mechanism Vestibular + Nootropic Therapy
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Cogwise-Plus Tablet

Cogwise-Plus Tablet is a comprehensive multi-mechanism vestibular and nootropic combination: Betahistine 16 mg, Vitamin D3 400 IU, Ginkgo Biloba 60 mg, Piracetam 400 mg and Vinpocetine 5 mg. Used for Meniere’s disease, vertigo, tinnitus, age-related cognitive impairment and cerebral circulatory disorders.

The combination addresses vestibular function (Betahistine), cerebral circulation (Ginkgo, Vinpocetine), neuronal membrane function (Piracetam) and bone health (Vitamin D3). Particularly used in elderly patients with concurrent vertigo, mild cognitive impairment and vascular concerns.

Cogwise-Plus is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a specialty neurology SKU.

Indications

  • Meniere's disease symptoms (vertigo, tinnitus, hearing loss)
  • Vertigo of various causes
  • Age-related memory impairment
  • Vascular dementia
  • Cerebral circulation disorders
  • Tinnitus

Mechanism of Action

Betahistine acts on histamine H1 (agonist) and H3 (antagonist) receptors improving inner-ear microcirculation and central vestibular compensation. Ginkgo Biloba improves cerebral microcirculation and has antioxidant action. Piracetam modulates neuronal membrane fluidity. Vinpocetine selectively improves cerebral blood flow via vasodilation and antiplatelet action.

Dosage & Administration

Adults: 1 tablet twice daily. Long-term use as advised by physician.

Side Effects

Mild GI upset, headache, occasional flushing. Rare hypersensitivity.

Contraindications & Precautions

Hypersensitivity. Active peptic ulcer (Betahistine). Phaeochromocytoma. Pregnancy and lactation. Severe hepatic impairment.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Cogwise-Plus Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Cogwise-Plus used for?

Cogwise-Plus contains Betahistine + Ginkgo + Piracetam + Vinpocetine. Used as per the indications described above.

How should Cogwise-Plus be taken?

As directed by your physician. Complete the prescribed course.

Is Cogwise-Plus available for PCD pharma franchise?

Yes, Trumac Healthcare offers Cogwise-Plus on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Cogwise-Plus be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Cogwise-Plus WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.